STRING: 39946.BGIOSGA017337-PA
RR6 Antibody is a polyclonal antibody raised in rabbits against recombinant Oryza sativa subsp. indica (Rice) RR6 protein. It specifically recognizes and binds to RR6 protein in rice (Oryza sativa subsp. indica), making it valuable for plant molecular biology research . The antibody undergoes antigen affinity purification to ensure target specificity and reduce background noise in experiments. This antibody should not be confused with RPS6 antibody, which targets ribosomal protein S6 and serves as a ribosome marker in human cells .
RR6 Antibody has been validated for several research applications including:
Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative detection of RR6 protein
Western Blotting (WB): For identification of RR6 protein in complex mixtures
When designing experiments, researchers should note that while these applications have been validated, optimization may be required for specific experimental conditions. The antibody is provided in liquid form with a storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative .
To maintain optimal activity and prevent degradation of RR6 Antibody, researchers should:
Store the antibody at -20°C or -80°C immediately upon receipt
Avoid repeated freeze-thaw cycles as these can significantly reduce antibody functionality
Consider aliquoting the antibody into smaller volumes for single-use applications to minimize freeze-thaw cycles
Long-term stability studies suggest that properly stored antibodies retain their activity for extended periods, though periodic validation is recommended for critical experiments.
For optimal Western blot results with RR6 Antibody, researchers should consider:
Sample preparation: Extract plant proteins using appropriate buffers that preserve protein integrity while minimizing interference from plant-specific compounds
Blocking optimization: Test different blocking agents (BSA vs. milk) as plant antibodies may have different specificities
Dilution optimization: Begin with manufacturer-recommended dilutions (typically 1:1000) and adjust based on signal-to-noise ratio
Incubation conditions: Optimize temperature (4°C overnight vs. room temperature for 1-2 hours) and incubation time
Detection system selection: Choose between chemiluminescence, fluorescence, or colorimetric detection based on required sensitivity
Similar to approaches used with camelid antibodies in research contexts, optimization may require iterative testing to achieve reproducible results .
Validating RR6 Antibody specificity is crucial for reliable experimental results. Researchers should:
Include positive controls: Use purified recombinant RR6 protein or samples known to express RR6
Include negative controls: Test samples from species or tissues not expected to express RR6
Perform peptide competition assays: Pre-incubate the antibody with immunizing peptide to confirm binding specificity
Compare with genetic approaches: Correlate antibody detection with gene expression data (RT-PCR or RNA-seq)
Test RR6 knockout/knockdown samples: If available, samples with reduced RR6 expression should show reduced antibody binding
These validation steps are particularly important for plant antibodies where cross-reactivity with other plant proteins can be challenging to predict.
For effective immunohistochemistry with RR6 Antibody in plant tissues:
Fixation: Use 4% paraformaldehyde in PBS for 12-24 hours, depending on tissue thickness
Embedding: Paraffin embedding is recommended for most applications, though cryosectioning may be preferable for certain experiments
Antigen retrieval: Heat-induced epitope retrieval using citrate buffer (pH 6.0) helps expose antigens that may be masked during fixation
Section thickness: 5-10 μm sections typically provide optimal results
Permeabilization: Include a permeabilization step with 0.1-0.5% Triton X-100 to facilitate antibody penetration into plant cell walls
These approaches are adapted from established protocols for plant immunohistochemistry and may require further optimization based on specific tissue types.
RR6 Antibody can be valuable for studying stress responses in rice through:
Protein expression analysis: Monitor RR6 protein levels under different stress conditions (drought, salinity, pathogen exposure) using Western blot or ELISA
Protein localization studies: Track potential changes in RR6 subcellular localization during stress responses using immunofluorescence
Co-immunoprecipitation: Identify stress-specific protein interaction partners of RR6
Chromatin immunoprecipitation (if RR6 has DNA-binding properties): Assess potential changes in RR6-DNA interactions during stress responses
These approaches can provide insights into how RR6 protein function may be regulated during plant stress adaptation, similar to methodologies used in other plant antibody research contexts.
When conducting comparative studies across rice varieties with RR6 Antibody:
Sequence alignment: Compare RR6 protein sequences across target rice varieties to identify potential amino acid variations that might affect antibody recognition
Validation in each variety: Verify antibody specificity separately in each rice variety before comparative analyses
Quantification standards: Include internal loading controls specific to each variety to normalize expression data
Cross-reactivity testing: Test for potential cross-reactivity with homologous proteins in different varieties
Standardized extraction: Use identical extraction protocols across varieties to ensure comparable protein yields
These considerations help ensure that observed differences reflect genuine biological variation rather than technical artifacts.
The development of camelid single-domain antibodies (VHH) against targets like RR6 can benefit from structural modeling approaches:
Homology modeling: Using tools like RosettaAntibody, researchers can predict the structure of VHH domains against RR6, which is particularly valuable given the unique features of camelid antibodies including longer CDR H1 and H3 loops
Epitope prediction: Computational approaches can identify potential binding sites on RR6 protein
Affinity optimization: Structure-guided mutations can be introduced to enhance binding affinity
Humanization strategies: For potential therapeutic applications, structural models guide the humanization process while maintaining binding specificity
The cAb VHH-R2 anti-RR6 antibody (1QD0) represents a unique case with a 13-residue CDR H1, highlighting the structural diversity possible in targeting RR6 .
When encountering non-specific binding with RR6 Antibody:
Optimize blocking conditions: Test different blocking agents (5% BSA, 5% milk, commercial blocking buffers) and increased blocking times
Adjust antibody dilution: Increase dilution factor (1:2000 or 1:5000) to reduce non-specific binding
Modify washing protocols: Increase wash duration and number of washes with added detergent (0.1-0.5% Tween-20)
Pre-adsorption: Consider pre-adsorbing the antibody with proteins from non-target tissues
Buffer optimization: Test different buffer compositions and pH conditions
Secondary antibody concentration: Reduce secondary antibody concentration or switch to more specific alternatives
These approaches can significantly improve signal-to-noise ratio in RR6 Antibody applications.
For reliable quantification of Western blot data:
Use appropriate loading controls: Plant-specific housekeeping proteins like actin or tubulin
Ensure linear dynamic range: Validate that signal intensity correlates linearly with protein amount loaded
Replicate analysis: Perform at least three biological replicates and technical replicates
Densitometry software: Use specialized software (ImageJ, Image Lab) with background subtraction
Normalization approach: Express target protein as ratio to loading control
Statistical analysis: Apply appropriate statistical tests (t-test, ANOVA) based on experimental design
This systematic approach ensures quantitative data is reliable and reproducible across experiments.
When encountering contradictory results:
Antibody validation reassessment: Re-verify antibody specificity under each experimental condition
Protocol standardization: Systematically document and control all experimental variables
Technical replication: Increase the number of technical and biological replicates
Alternative approaches: Complement antibody-based detection with orthogonal methods (mass spectrometry, genetic approaches)
Condition-specific controls: Develop positive and negative controls specific to each experimental condition
Expert consultation: Consult with researchers experienced in similar experimental systems
This systematic troubleshooting approach can help identify sources of variability and resolve contradictory findings.
Recent research on extrafollicular B cell responses might provide insights for developing advanced antibody tools targeting proteins like RR6:
The extrafollicular B cell response is characterized by expansion of atypical B cells, marginal zone-like B cells, and antibody-secreting cells, which could inform antibody development strategies
Understanding the response to treatments like rituximab (RTX) could help develop more effective antibody-based tools for research applications
The recognition of T-bet+ CD11c+ B cells as important sources for short-lived antibody-secreting cells might inform approaches to antibody generation and selection
These emerging concepts from immune research could inspire new approaches to antibody design and application in plant biology research.
Advanced computational methods can enhance RR6 Antibody research:
Structure-based antibody design: Using computational tools to predict antibody-antigen interactions at atomic resolution
Integration of binding affinity data: Using experimental binding data to filter potential docking orientations in computational models
Fragment-based approaches: Using specific structural fragments like the six-residue C-terminal CDR H3 fragment library to model antibody structure and function
Loop modeling: Enhanced protocols for modeling complex structures, particularly for antibodies with extremely long CDR H3 loops
These computational approaches can guide antibody engineering or therapeutic design by creating constraints for atomic-resolution docking and discriminating between residue-scale models .
The trend toward animal-free antibody production has several implications for RR6 research:
Ethical compliance: New production methods align with increasing ethical standards in research, potentially increasing adoption of RR6 Antibody in diverse research contexts
Reproducibility improvements: Animal-free production may enhance batch-to-batch consistency, addressing a key challenge in antibody research
Scalability: Easier scale-up of production could make RR6 Antibody more accessible for large-scale studies
Customization potential: Animal-free systems might facilitate the production of modified versions of RR6 Antibody for specialized applications
These developments could significantly impact how RR6 Antibody is produced and utilized in future research.